Base de dados : MEDLINE
Pesquisa : C04.557.435.525 [Categoria DeCS]
Referências encontradas : 286 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 29 ir para página                         

  1 / 286 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28132963
[Au] Autor:Watanabe KI; Chambers JK; Uchida K; Nibe K; Ushio N; Horiuchi N; Kobayashi Y; Nakayama H
[Ad] Endereço:Department of Veterinary Medicine, Research Center for Global Agromedicine, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-0834, Japan.
[Ti] Título:A cutaneous mixed tumor in a dog.
[So] Source:J Vet Med Sci;79(3):670-673, 2017 Mar 28.
[Is] ISSN:1347-7439
[Cp] País de publicação:Japan
[La] Idioma:eng
[Ab] Resumo:The atypical cutaneous tumor of a 9-year-old mixed breed female dog was examined. The tumor was well-demarcated and histologically composed of a trichoblastic area, tricholemmal area and apocrine glandular area. Neoplastic cells in trichoblastic area and tricholemmal area had PAS-positive granules in the cytoplasm and were positive for pan-cytokeratin, cytokeratin 5/6, 14 and 19 and p63. Neoplastic cells in trichoblastic area were also positive for cytokeratin 15 and CD34. Neoplastic cells in apocrine glandular area were positive for pan-cytokeratin and cytokeratin 7, 18 and 19. Myoepithelial cell proliferation with osteocartilaginous metaplasia was observed in this area. Since neoplastic cells showed multiphenotypic differentiation for hair follicles and apocrine glands, the present case was diagnosed as a cutaneous mixed tumor.
[Mh] Termos MeSH primário: Doenças do Cão/patologia
Tumor Misto Maligno/veterinária
Neoplasias Cutâneas/veterinária
[Mh] Termos MeSH secundário: Animais
Cães
Feminino
Tumor Misto Maligno/patologia
Neoplasias Cutâneas/patologia
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170726
[Lr] Data última revisão:
170726
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170131
[St] Status:MEDLINE
[do] DOI:10.1292/jvms.16-0610


  2 / 286 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27262834
[Au] Autor:Friedman C; Fenster T
[Ad] Endereço:Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York. Electronic address: cff9001@nyp.org.
[Ti] Título:Laparoscopic Treatment of Mixed Malignant Ovarian Germ Cell Tumor in a 16-Year-Old Female Adolescent.
[So] Source:J Pediatr Adolesc Gynecol;29(6):e91-e94, 2016 Dec.
[Is] ISSN:1873-4332
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Malignant ovarian germ cell tumors are rare entities, although they account for a large proportion of ovarian masses in young women. These tumors have traditionally been removed via laparotomy, because of their large size and solid nature. The use of laparoscopy for treatment of adnexal masses in adolescents has been heavily debated and poorly studied to date. CASE: A 16-year-old female patient presented with abdominal pain and an 11-cm adnexal mass on ultrasound. An emergent laparoscopic salpingo-oophorectomy was performed without complication. Pathology revealed a mixed malignant ovarian germ cell tumor. SUMMARY AND CONCLUSION: Laparoscopic fertility-sparing surgery offers many benefits over laparotomy, and should be considered in cases of young women with large adnexal masses, even if potential for malignancy exists.
[Mh] Termos MeSH primário: Laparoscopia
Tumor Misto Maligno/cirurgia
Neoplasias Embrionárias de Células Germinativas/cirurgia
Neoplasias Ovarianas/cirurgia
Ovariectomia/métodos
[Mh] Termos MeSH secundário: Dor Abdominal/etiologia
Doenças dos Anexos/etiologia
Adolescente
Feminino
Seres Humanos
Tumor Misto Maligno/complicações
Neoplasias Embrionárias de Células Germinativas/complicações
Neoplasias Ovarianas/complicações
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1703
[Cu] Atualização por classe:170817
[Lr] Data última revisão:
170817
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160606
[St] Status:MEDLINE


  3 / 286 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27128301
[Au] Autor:Kim JY; Hong SM
[Ti] Título:Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
[So] Source:Arch Pathol Lab Med;140(5):437-48, 2016 May.
[Is] ISSN:1543-2165
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:CONTEXT: -Gastrointestinal (GI) and pancreatobiliary tracts contain a variety of neuroendocrine cells that constitute a diffuse endocrine system. Neuroendocrine tumors (NETs) from these organs are heterogeneous tumors with diverse clinical behaviors. Recent improvements in the understanding of NETs from the GI and pancreatobiliary tracts have led to more-refined definitions of the clinicopathologic characteristics of these tumors. Under the 2010 World Health Organization classification scheme, NETs are classified as grade (G) 1 NETs, G2 NETs, neuroendocrine carcinomas, and mixed adenoneuroendocrine carcinomas. Histologic grades are dependent on mitotic counts and the Ki-67 labeling index. Several new issues arose after implementation of the 2010 World Health Organization classification scheme, such as issues with well-differentiated NETs with G3 Ki-67 labeling index and the evaluation of mitotic counts and Ki-67 labeling. Hereditary syndromes, including multiple endocrine neoplasia type 1 syndrome, von Hippel-Lindau syndrome, neurofibromatosis 1, and tuberous sclerosis, are related to NETs of the GI and pancreatobiliary tracts. Several prognostic markers of GI and pancreatobiliary tract NETs have been introduced, but many of them require further validation. OBJECTIVE: -To understand clinicopathologic characteristics of NETs from the GI and pancreatobiliary tracts. DATA SOURCES: -PubMed (US National Library of Medicine) reports were reviewed. CONCLUSIONS: -In this review, we briefly summarize recent developments and issues related to NETs of the GI and pancreatobiliary tracts.
[Mh] Termos MeSH primário: Neoplasias do Sistema Biliar/diagnóstico
Neoplasias Gastrointestinais/diagnóstico
Células Neuroendócrinas/patologia
Tumores Neuroendócrinos/diagnóstico
Neoplasias Pancreáticas/diagnóstico
Patologia Clínica/métodos
[Mh] Termos MeSH secundário: Sistema Biliar/metabolismo
Sistema Biliar/patologia
Neoplasias do Sistema Biliar/metabolismo
Neoplasias do Sistema Biliar/patologia
Biomarcadores Tumorais/metabolismo
Carcinoma Neuroendócrino/diagnóstico
Carcinoma Neuroendócrino/metabolismo
Carcinoma Neuroendócrino/patologia
Diagnóstico Diferencial
Educação Médica Continuada
Neoplasias Gastrointestinais/metabolismo
Neoplasias Gastrointestinais/patologia
Trato Gastrointestinal/metabolismo
Trato Gastrointestinal/patologia
Seres Humanos
Índice Mitótico
Tumor Misto Maligno/diagnóstico
Tumor Misto Maligno/metabolismo
Tumor Misto Maligno/patologia
Gradação de Tumores
Estadiamento de Neoplasias
Células Neuroendócrinas/metabolismo
Tumores Neuroendócrinos/metabolismo
Tumores Neuroendócrinos/patologia
Pâncreas/metabolismo
Pâncreas/patologia
Neoplasias Pancreáticas/metabolismo
Neoplasias Pancreáticas/patologia
Patologia Clínica/educação
Patologia Clínica/recursos humanos
Patologia Clínica/tendências
Guias de Prática Clínica como Assunto
Prognóstico
Organização Mundial da Saúde
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Biomarkers, Tumor)
[Em] Mês de entrada:1702
[Cu] Atualização por classe:170817
[Lr] Data última revisão:
170817
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:160430
[St] Status:MEDLINE
[do] DOI:10.5858/arpa.2015-0314-RA


  4 / 286 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26980026
[Au] Autor:Zhang L; Shimizu D; Killeen JL; Honda SA; Lu D; Stanoyevitch A; Lin F; Wang B; Monuki ES; Carbone M
[Ad] Endereço:The Department of Pathology, John A. Burn School of Medicine, the University of Hawaii, Honolulu, HI 96813; The Clinical Informatics Fellowship Program, University of California at Los Angeles, Los Angeles, CA 90095. Electronic address: lei_248@hotmail.com.
[Ti] Título:Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor.
[So] Source:Hum Pathol;53:159-67, 2016 Jul.
[Is] ISSN:1532-8392
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The stage I uterine malignant mixed mullerian tumor (MMMT) shows different potential for progression. We reason that MMMTs with high-grade carcinomatous component and positivity for HB-EGF are prone to recurrence/metastasis in the early stage. A retrospective clinical and histopathologic review with immunohistochemical staining for HB-EGF, EGFR, and integrin-α5 was performed for 62 surgically staged MMMT cases. Recurrence/metastasis (RM) is 6/18 (33%) in stage I disease. Of all the clinicopathologic variables and biomarkers analyzed for stage I MMMT, serous carcinomatous component (83% [5/6] versus 17% [1/12], P = .0015) and HB-EGF expression (100% [6/6] versus 50% [6/12], P=.0339) were significantly different between groups with RM and without RM. The presence of serous carcinoma in all stages was 83% (5/6) in stage I with RM, 8% (1/12) in stage I without RM, 20% (1/5) in stage II, 36.4% (8/22) in stage III and 64.7% (11/17) in stage IV; this was paralleled by HB-EGF expression of 100% (6/6), 50% (6/12), 40% (2/5), 50% (11/22) and 71% (12/17) with a correlation coefficient r=0.9131 (P=.027). HB-EGF and integrin-α5 were highly expressed in MMMTs bearing serous carcinoma component, compared to endometrioid and unclassifiable/miscellaneous subtypes (84.6%/47.6%/33.3%, P=.025 for HB-EGF; and 61.5%/42.9%/20.0%, P=.021 for integrin-α5). The EGFR positivity was comparable among the three subtypes (48.1%, 47.6% and 26.7%, P=.326). This study indicates that serous carcinomatous component championed by expression of HB-EGF predisposes to recurrence/metastasis in stage I MMMT. This process might involve integrin-α5 and does not seem to require overexpression of EGFR. Further study is required.
[Mh] Termos MeSH primário: Biomarcadores Tumorais/análise
Movimento Celular
Fator de Crescimento Semelhante a EGF de Ligação à Heparina/análise
Tumor Misto Maligno/química
Tumor Mulleriano Misto/química
Recidiva Local de Neoplasia
Neoplasias Císticas, Mucinosas e Serosas/química
Neoplasias Uterinas/química
[Mh] Termos MeSH secundário: Idoso
Feminino
Seres Humanos
Imuno-Histoquímica
Integrina alfa5/análise
Meia-Idade
Tumor Misto Maligno/secundário
Tumor Misto Maligno/cirurgia
Tumor Mulleriano Misto/secundário
Tumor Mulleriano Misto/cirurgia
Invasividade Neoplásica
Estadiamento de Neoplasias
Neoplasias Císticas, Mucinosas e Serosas/secundário
Neoplasias Císticas, Mucinosas e Serosas/cirurgia
Receptor do Fator de Crescimento Epidérmico/análise
Estudos Retrospectivos
Análise Serial de Tecidos
Resultado do Tratamento
Neoplasias Uterinas/patologia
Neoplasias Uterinas/cirurgia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Biomarkers, Tumor); 0 (Heparin-binding EGF-like Growth Factor); 0 (Integrin alpha5); EC 2.7.10.1 (EGFR protein, human); EC 2.7.10.1 (Receptor, Epidermal Growth Factor)
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170814
[Lr] Data última revisão:
170814
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160317
[St] Status:MEDLINE


  5 / 286 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26848585
[Au] Autor:Kaji K; Seishima J; Yamato M; Miyazawa M; Komura T; Marukawa Y; Ohta H; Kasashima S; Kawashima A; Yano M; Unoura M
[Ad] Endereço:Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Kanazawa, Japan. bonchi.tasuke@gmail.com.
[Ti] Título:Clinical utility of endoscopic ultrasound-guided fine-needle aspiration in mixed adenoneuroendocrine carcinoma with signet-ring cells of the pancreas: a case report and review of the literature.
[So] Source:Clin J Gastroenterol;9(1):43-8, 2016 Feb.
[Is] ISSN:1865-7265
[Cp] País de publicação:Japan
[La] Idioma:eng
[Ab] Resumo:A man in his 60s visited our hospital because of a pancreatic head tumor. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) revealed that the tumor consisted of a neuroendocrine carcinoma (NEC) and adenocarcinoma, including signet-ring cell carcinoma, and that the ratio of these components was approximately 50:50. Therefore, he was diagnosed with mixed adenoneuroendocrine carcinoma (MANEC). Because of liver and lymph node metastases, systemic chemotherapy was initiated using a regimen for the NEC component based on an increase in neuron-specific enolase (NSE). Although the patient achieved stable disease after two chemotherapy cycles, the tumor increased in size after three cycles, which was associated with a gradual increase in carcinoembryonic antigen and a decrease in NSE level. An EUS-FNA reexamination revealed that the adenocarcinoma component accounted for 90 % of the tumor. Thus, an adenocarcinoma chemotherapy regimen was started, and a slight reduction in tumor size was observed. Here, we report an extremely rare and remarkable case of MANEC of the pancreas that demonstrates the effectiveness of EUS-FNA for helping to decide the chemotherapy regimen.
[Mh] Termos MeSH primário: Carcinoma Neuroendócrino/patologia
Carcinoma de Células em Anel de Sinete/patologia
Aspiração por Agulha Fina Guiada por Ultrassom Endoscópico/métodos
Tumor Misto Maligno/patologia
Neoplasias Pancreáticas/patologia
[Mh] Termos MeSH secundário: Idoso
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico
Carcinoma Neuroendócrino/diagnóstico
Carcinoma Neuroendócrino/tratamento farmacológico
Carcinoma de Células em Anel de Sinete/diagnóstico
Carcinoma de Células em Anel de Sinete/tratamento farmacológico
Seres Humanos
Masculino
Tumor Misto Maligno/diagnóstico
Tumor Misto Maligno/tratamento farmacológico
Imagem Multimodal
Neoplasias Pancreáticas/diagnóstico
Neoplasias Pancreáticas/tratamento farmacológico
Tomografia por Emissão de Pósitrons
Tomografia Computadorizada por Raios X
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1611
[Cu] Atualização por classe:171110
[Lr] Data última revisão:
171110
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160206
[St] Status:MEDLINE
[do] DOI:10.1007/s12328-016-0625-z


  6 / 286 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26699873
[Au] Autor:Komatsubara T; Koinuma K; Miyakura Y; Horie H; Morimoto M; Ito H; Lefor AK; Sata N; Fukushima N
[Ad] Endereço:Department of Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan. edy-sot@nifty.com.
[Ti] Título:Endocrine cell carcinomas of the colon and rectum: a clinicopathological evaluation.
[So] Source:Clin J Gastroenterol;9(1):1-6, 2016 Feb.
[Is] ISSN:1865-7265
[Cp] País de publicação:Japan
[La] Idioma:eng
[Ab] Resumo:PURPOSE: Endocrine cell carcinoma, according to the Japanese classification criteria for colorectal cancer, corresponds to neuroendocrine carcinoma (NEC) and mixed adenoneuroendocrine carcinoma (MANEC), as defined in the 2010 World Health Organization (WHO) classification. We retrospectively reviewed the clinical features of patients with these tumors diagnosed and treated at our institution. METHODS: The clinicopathological features of endocrine cell carcinomas of the colon and rectum diagnosed by neuroendocrine markers from January 2000 to December 2012 were retrospectively evaluated in 12 patients. RESULTS: Surgical specimens were obtained from eight of the 12 patients. MANEC was diagnosed in six patients and NEC in one. One tumor was unclassifiable. The tumors were not resected in four patients, and all died within 3 months. Of the eight patients who underwent resection, four received an R0 resection, two of whom underwent adjuvant chemotherapy and survived more than 5 years. One patient who underwent an R2 resection and continuous chemotherapy survived for 53 months. One patient with NEC underwent surgery and radiotherapy, and died 17 months later. CONCLUSION: Most endocrine cell carcinomas of the colon and rectum reviewed were MANECs. Though their prognosis was generally poor, chemotherapy may be effective in some patients.
[Mh] Termos MeSH primário: Carcinoma Neuroendócrino/patologia
Neoplasias Colorretais/patologia
[Mh] Termos MeSH secundário: Adenocarcinoma/patologia
Adenocarcinoma/terapia
Adulto
Idoso
Idoso de 80 Anos ou mais
Carcinoma Neuroendócrino/terapia
Neoplasias Colorretais/terapia
Feminino
Seres Humanos
Masculino
Meia-Idade
Tumor Misto Maligno/patologia
Tumor Misto Maligno/terapia
Prognóstico
Estudos Retrospectivos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1611
[Cu] Atualização por classe:171110
[Lr] Data última revisão:
171110
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:151225
[St] Status:MEDLINE
[do] DOI:10.1007/s12328-015-0623-6


  7 / 286 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
[PMID]:25885489
[Au] Autor:Cazzo E; de Saito HP
[Ad] Endereço:Department of Surgery, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.
[Ti] Título:Mixed adenoneuroendocrine carcinoma of the gastric stump following Billroth II gastrectomy: case report and review of the literature.
[So] Source:Sao Paulo Med J;134(1):84-7, 2016 Jan-Feb.
[Is] ISSN:1806-9460
[Cp] País de publicação:Brazil
[La] Idioma:eng
[Ab] Resumo:CONTEXT: Gastric stump cancer after gastric resection is a well-known disease. It may be a newly developed cancer after resection due to benign disease, or recurrent or residual disease after oncological surgery. The predominant histological type is usually adenocarcinoma. This study aimed to report on a rare occurrence of a mixed adenoneuroendocrine carcinoma (MANEC) on the gastric stump. CASE REPORT: The case of an 83-year-old female who presented a locally aggressive gastric stump MANEC, 35 years after Billroth II gastrectomy to treat a peptic ulcer, is reported. The patient underwent resection and adjuvant therapy. She has been followed up for one year without signs of recurrence. CONCLUSION: MANEC is a rare type of gastrointestinal neoplasm. The classification, histopathology, clinical features, treatment issues and prognosis are discussed along with a brief review of the literature.
[Mh] Termos MeSH primário: Adenocarcinoma/cirurgia
Carcinoma Neuroendócrino/cirurgia
Coto Gástrico/cirurgia
Tumor Misto Maligno/cirurgia
Neoplasias Gástricas/cirurgia
[Mh] Termos MeSH secundário: Adenocarcinoma/terapia
Idoso de 80 Anos ou mais
Carcinoma Neuroendócrino/terapia
Quimiorradioterapia Adjuvante/métodos
Feminino
Gastroenterostomia
Seres Humanos
Tumor Misto Maligno/terapia
Neoplasias Gástricas/terapia
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1612
[Cu] Atualização por classe:161230
[Lr] Data última revisão:
161230
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150418
[St] Status:MEDLINE


  8 / 286 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:25074531
[Au] Autor:Imafuku K; Hata H; Kitamura S; Iwata H; Shimizu H
[Ad] Endereço:Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
[Ti] Título:Ultrasound B-mode and elastographic findings of mixed tumour of the skin on the scalp.
[So] Source:J Eur Acad Dermatol Venereol;30(1):153-5, 2016 Jan.
[Is] ISSN:1468-3083
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Tumor Misto Maligno/diagnóstico por imagem
Couro Cabeludo/diagnóstico por imagem
Neoplasias Cutâneas/diagnóstico por imagem
Ultrassonografia/métodos
[Mh] Termos MeSH secundário: Diagnóstico Diferencial
Técnicas de Imagem por Elasticidade
Feminino
Seres Humanos
Meia-Idade
Tumor Misto Maligno/patologia
Couro Cabeludo/patologia
Neoplasias Cutâneas/patologia
[Pt] Tipo de publicação:CASE REPORTS; LETTER
[Em] Mês de entrada:1612
[Cu] Atualização por classe:161230
[Lr] Data última revisão:
161230
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:140731
[St] Status:MEDLINE
[do] DOI:10.1111/jdv.12644


  9 / 286 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:26437156
[Au] Autor:Cohen PR
[Ad] Endereço:University of California San Diego.
[Ti] Título:Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid.
[So] Source:Dermatol Online J;21(8), 2015 Aug 15.
[Is] ISSN:1087-2108
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Baboon syndrome is a distinctive skin reaction in which the patient typically develops erythematous buttocks that appear similar to those of a baboon. The non-contact allergenic variant of baboon syndrome is also referred to as symmetrical drug-related intertriginous and flexural exanthema (SDRIFE). Zoledronic acid is a bisphosphonate that is used in patients with metastatic cancer to prevent bone complications. PURPOSE: Zoledronic acid-associated baboon syndrome is described in a woman with recurrent metastatic breast cancer. METHODS: PubMed was used to search the following terms, separately and in combination: baboon syndrome, breast cancer, symmetrical drug-related intertriginous and flexural exanthema, and zoledronic acid. All papers were reviewed and relevant manuscripts, along with their reference citations, were evaluated. RESULTS: Zoledronic acid has infrequently been associated with mucocutaneous adverse reactions. However, baboon syndrome has not previously been observed in patients receiving zoledronic acid. The reported woman developed baboon syndrome after her initial exposure to zoledronic acid. CONCLUSIONS: Non-contact allergenic drug-induced baboon syndrome has most commonly been associated with antibiotics such as beta-lactams and penicillins. Zoledronic acid-associated baboon syndrome has not previously been observed in cancer patients. Baboon syndrome (SDRIFE variant) was observed in a woman with recurrent metastatic breast cancer after her first exposure to zoledronic acid. In summary, SDRIFE can occur in oncology patients receiving zoledronic acid and zoledronic acid should be added to the list of medications associated with the potential to cause non-contact allergenic drug-induced baboon syndrome.
[Mh] Termos MeSH primário: Conservadores da Densidade Óssea/efeitos adversos
Neoplasias Ósseas/secundário
Neoplasias da Mama/secundário
Carcinoma Ductal de Mama/secundário
Carcinoma Lobular/secundário
Difosfonatos/efeitos adversos
Erupção por Droga/etiologia
Eritema/induzido quimicamente
Imidazóis/efeitos adversos
Intertrigo/induzido quimicamente
Tumor Misto Maligno/secundário
[Mh] Termos MeSH secundário: Braço
Axila
Conservadores da Densidade Óssea/uso terapêutico
Neoplasias Ósseas/tratamento farmacológico
Neoplasias da Mama/tratamento farmacológico
Neoplasias da Mama/terapia
Nádegas
Carcinoma Ductal de Mama/tratamento farmacológico
Carcinoma Ductal de Mama/terapia
Carcinoma Lobular/tratamento farmacológico
Carcinoma Lobular/terapia
Terapia Combinada
Difosfonatos/uso terapêutico
Feminino
Seres Humanos
Imidazóis/uso terapêutico
Neoplasias Pulmonares/secundário
Meia-Idade
Tumor Misto Maligno/tratamento farmacológico
Tumor Misto Maligno/terapia
Síndrome
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Bone Density Conservation Agents); 0 (Diphosphonates); 0 (Imidazoles); 6XC1PAD3KF (zoledronic acid)
[Em] Mês de entrada:1607
[Cu] Atualização por classe:151006
[Lr] Data última revisão:
151006
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:151006
[St] Status:MEDLINE


  10 / 286 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26387607
[Au] Autor:Decaussin-Petrucci M
[Ad] Endereço:Service d'anatomie et cytologie pathologiques, CHU Lyon Sud, chemin du Grand-Revoyet, 69495 Pierre-Bénite cedex, France. Electronic address: myriam.decaussin-petrucci@chu-lyon.fr.
[Ti] Título:[Thyroid pathology. Case No. 6. Thyroid undifferentiated carcinoma (anaplasic) developed on a papillary carcinoma].
[Ti] Título:Pathologie de la thyroïde. Cas n(o) 6. Carcinome indifférencié (anaplasique) de la thyroïde développé sur un carcinome papillaire..
[So] Source:Ann Pathol;35(5):419-24, 2015 Oct.
[Is] ISSN:0242-6498
[Cp] País de publicação:France
[La] Idioma:fre
[Mh] Termos MeSH primário: Carcinoma Papilar/patologia
Carcinoma/patologia
Tumor Misto Maligno/patologia
Neoplasias da Glândula Tireoide/patologia
[Mh] Termos MeSH secundário: Biomarcadores Tumorais
Carcinoma/complicações
Carcinoma/cirurgia
Carcinoma Papilar/complicações
Diagnóstico Diferencial
Bócio/complicações
Bócio/patologia
Seres Humanos
Masculino
Meia-Idade
Tumor Misto Maligno/complicações
Sarcoma/diagnóstico
Neoplasias da Glândula Tireoide/complicações
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Biomarkers, Tumor)
[Em] Mês de entrada:1608
[Cu] Atualização por classe:151011
[Lr] Data última revisão:
151011
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150922
[St] Status:MEDLINE



página 1 de 29 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde